Black Americans Underrepresented in Clinical Trials of Cardiovascular Drugs

NEW YORK (Reuters Health) – Black U.S. residents have been significantly underrepresented in pivotal clinical trials of 24 cardiovascular drugs that received Food and Drug Administration (FDA) approval during the last 15 years, according to two researchers in China. The underrepresentation could undermine the generalizability of the trials and the use of new cardiovascular drugs in Black Americans, they write […]

Read more